Conference Reports for NATAP

(APASL) 23rd Conference of the Asian Pacific Association for the Study of the Liver 6-9 June 2013, Singapore Back

High SVR24 rates with ritonavir-boosted danoprevir (DNVr) plus PegIFN alfa-2a/ribavirin (P/R) in HCV genotype (G)1/4-infected treatment-naive patients: the DAUPHINE study       Reported by Jules Levin APASL - Asian Pacific Association for the Study of the Liver (APASL) Liver Week, June 6-10, 2013, Singapore